Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1949158696;58697;58698 chr2:178593829;178593828;178593827chr2:179458556;179458555;179458554
N2AB1785053773;53774;53775 chr2:178593829;178593828;178593827chr2:179458556;179458555;179458554
N2A1692350992;50993;50994 chr2:178593829;178593828;178593827chr2:179458556;179458555;179458554
N2B1042631501;31502;31503 chr2:178593829;178593828;178593827chr2:179458556;179458555;179458554
Novex-11055131876;31877;31878 chr2:178593829;178593828;178593827chr2:179458556;179458555;179458554
Novex-21061832077;32078;32079 chr2:178593829;178593828;178593827chr2:179458556;179458555;179458554
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: E
  • RefSeq wild type transcript codon: GAG
  • RefSeq wild type template codon: CTC
  • Domain: Fn3-29
  • Domain position: 13
  • Structural Position: 14
  • Q(SASA): 0.3329
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
E/V rs2050771375 None 1.0 N 0.7 0.603 0.556695477184 gnomAD-3.1.2 6.58E-06 None None None None N None 0 0 0 0 0 None 0 0 0 0 4.78469E-04
E/V rs2050771375 None 1.0 N 0.7 0.603 0.556695477184 gnomAD-4.0.0 6.57851E-06 None None None None N None 0 0 None 0 0 None 0 0 0 0 4.78469E-04

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
E/A 0.2837 likely_benign 0.2937 benign -0.716 Destabilizing 0.999 D 0.662 neutral N 0.496951523 None None N
E/C 0.9162 likely_pathogenic 0.9243 pathogenic -0.517 Destabilizing 1.0 D 0.634 neutral None None None None N
E/D 0.1825 likely_benign 0.1971 benign -0.973 Destabilizing 0.999 D 0.429 neutral N 0.473266587 None None N
E/F 0.8883 likely_pathogenic 0.9045 pathogenic -0.069 Destabilizing 1.0 D 0.651 neutral None None None None N
E/G 0.4172 ambiguous 0.4569 ambiguous -1.063 Destabilizing 1.0 D 0.655 neutral N 0.469673718 None None N
E/H 0.6758 likely_pathogenic 0.6936 pathogenic -0.146 Destabilizing 1.0 D 0.59 neutral None None None None N
E/I 0.5908 likely_pathogenic 0.6049 pathogenic 0.227 Stabilizing 1.0 D 0.715 prob.delet. None None None None N
E/K 0.3161 likely_benign 0.3417 ambiguous -0.563 Destabilizing 0.999 D 0.582 neutral N 0.484018991 None None N
E/L 0.6582 likely_pathogenic 0.6856 pathogenic 0.227 Stabilizing 1.0 D 0.721 prob.delet. None None None None N
E/M 0.6293 likely_pathogenic 0.6478 pathogenic 0.459 Stabilizing 1.0 D 0.572 neutral None None None None N
E/N 0.439 ambiguous 0.4718 ambiguous -1.085 Destabilizing 1.0 D 0.709 prob.delet. None None None None N
E/P 0.9887 likely_pathogenic 0.9904 pathogenic -0.066 Destabilizing 1.0 D 0.728 prob.delet. None None None None N
E/Q 0.2743 likely_benign 0.2938 benign -0.936 Destabilizing 1.0 D 0.625 neutral N 0.488791931 None None N
E/R 0.5069 ambiguous 0.5277 ambiguous -0.167 Destabilizing 1.0 D 0.701 prob.neutral None None None None N
E/S 0.3584 ambiguous 0.3845 ambiguous -1.337 Destabilizing 0.999 D 0.643 neutral None None None None N
E/T 0.3649 ambiguous 0.3845 ambiguous -1.05 Destabilizing 1.0 D 0.737 prob.delet. None None None None N
E/V 0.3994 ambiguous 0.4075 ambiguous -0.066 Destabilizing 1.0 D 0.7 prob.neutral N 0.500148236 None None N
E/W 0.967 likely_pathogenic 0.9713 pathogenic 0.188 Stabilizing 1.0 D 0.639 neutral None None None None N
E/Y 0.8099 likely_pathogenic 0.831 pathogenic 0.172 Stabilizing 1.0 D 0.636 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.